Seglcellesygdom
Behandling af vaso-okklusive episoder og akut brystsyndrom
Smertebehandling
What is the best pharmacologic treatment for sickle cell disease pain crises? (åbner nyt vindue)
Kilde: Ann Emerg Med 2012;59(6):515-6.
Indekseret: PubMed 22221839
DOI: 10.1016/j.annemergmed.2011.11.026
https://www.ncbi.nlm.nih.gov/pubmed/22221839 (åbner nyt vindue)
Update on pain management in sickle cell disease. (åbner nyt vindue)
Kilde: Hemoglobin 2011;35(5-6):520-9.
Indekseret: PubMed 21910604
DOI: 10.3109/03630269.2011.610478
https://www.ncbi.nlm.nih.gov/pubmed/21910604 (åbner nyt vindue)
Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (åbner nyt vindue)
Kilde: Thromb Haemost 2007;98(2):392-6.
Indekseret: PubMed 17721622
https://www.ncbi.nlm.nih.gov/pubmed/17721622 (åbner nyt vindue)
Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management. (åbner nyt vindue)
Kilde: Acad Emerg Med 2012;19(4):430-8.
Indekseret: PubMed 22506947
DOI: 10.1111/j.1553-2712.2012.01330.x
https://www.ncbi.nlm.nih.gov/pubmed/22506947 (åbner nyt vindue)
Væsketerapi (væskebehandling)
Management of sickle cell disease. (åbner nyt vindue)
Kilde: BMJ 2008;337:a1397.
Indekseret: PubMed 18779222
https://www.ncbi.nlm.nih.gov/pubmed/18779222 (åbner nyt vindue)
Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (åbner nyt vindue)
Kilde: Cochrane Database Syst Rev 2012;(6):CD005406.
Indekseret: PubMed 22696351
DOI: 10.1002/14651858.CD005406.pub3
https://www.ncbi.nlm.nih.gov/pubmed/22696351 (åbner nyt vindue)
Iltsupplering
Low flow nocturnal oxygen therapy does not suppress haemoglobin levels or increase painful crises in sickle cell disease. (åbner nyt vindue)
Kilde: Br J Haematol 2013;161(3):455-6.
Indekseret: PubMed 23419066
DOI: 10.1111/bjh.12254
https://www.ncbi.nlm.nih.gov/pubmed/23419066 (åbner nyt vindue)
Guidelines for the management of the acute painful crisis in sickle cell disease. (åbner nyt vindue)
Kilde: Br J Haematol 2003;120(5):744-52.
Indekseret: PubMed 12614204
https://www.ncbi.nlm.nih.gov/pubmed/12614204 (åbner nyt vindue)
Hyperbaric oxygen therapy for vaso-occlusive crises in nine patients with sickle-cell disease. (åbner nyt vindue)
Kilde: Diving Hyperb Med 2012;42(2):82-4.
Indekseret: PubMed 22828815
https://www.ncbi.nlm.nih.gov/pubmed/22828815 (åbner nyt vindue)
Antibiotika og respiratorisk terapi
Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (åbner nyt vindue)
Kilde: Hemoglobin 2004;28(2):85-102.
Indekseret: PubMed 15182051
https://www.ncbi.nlm.nih.gov/pubmed/15182051 (åbner nyt vindue)
Incentive spirometry to prevent acute pulmonary complications in sickle cell diseases. (åbner nyt vindue)
Kilde: N Engl J Med 1995;333(11):699-703.
Indekseret: PubMed 7637747
DOI: 10.1056/NEJM199509143331104
https://www.ncbi.nlm.nih.gov/pubmed/7637747 (åbner nyt vindue)
Continuous inhaled nitric oxide therapy in a case of sickle cell disease with multiorgan involvement. (åbner nyt vindue)
Kilde: J Investig Med 2008;56(8):1023-7.
Indekseret: PubMed 19050460
DOI: 10.2310/JIM.0b013e31818cb612
https://www.ncbi.nlm.nih.gov/pubmed/19050460 (åbner nyt vindue)
Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. (åbner nyt vindue)
Kilde: N Engl J Med 2000;342(25):1855-65.
Indekseret: PubMed 10861320
DOI: 10.1056/NEJM200006223422502
https://www.ncbi.nlm.nih.gov/pubmed/10861320 (åbner nyt vindue)